Eremenko A, Balykov I, Chaus N, Kislukhin V, Krivitski N
Transonic Systems, Inc., Ithaca, New York 14850, USA.
ASAIO J. 1998 Sep-Oct;44(5):M462-4. doi: 10.1097/00002480-199809000-00028.
Thermodilution cardiac output (CO) measurement requires heart catheterization and is known as a risk factor. The existing cannula in the radial artery in intensive care unit (ICU) patients can be used to measure CO by ultrasound dilution (COus). An arteriovenous shunt between the radial artery and cubital vein was created using a 25 cm tubing loop. An ultrasound flow dilution sensor was clamped on the tubing and connected to a modified HD01 monitor (Transonic Systems, Inc., Ithaca, NY). Calibration injections of 1 ml 0.9% NaCl were injected into the tubing. An intravenous bolus injection consisted of 10-20 ml 0.9% NaCl. Simultaneously, CO was measured by thermal dilution (COth; MI 166A, Hewlett Packard, Andover, MA). Each value for COth or COus was based on the average of three to five injections. Blood flow through the shunt was 10 to 26 ml/min. The comparison was made on 14 patients. In 33 measurements, the regression equation was COth = -0.08 + 1.02 COus (r = 0.97). In 22 cases, the difference between COth and COus was less than 5%, in 9 cases it was in the range of 5-10%, and in 2 cases it was in the range of 10-20%. The presence of arterial and venous lines in an ICU setting obviates the need for cardiac catheterization for the determination of CO.
热稀释法心输出量(CO)测量需要进行心脏导管插入术,且已知这是一种风险因素。重症监护病房(ICU)患者桡动脉中现有的套管可用于通过超声稀释法(COus)测量CO。使用一个25厘米长的管道环在桡动脉和肘静脉之间建立动静脉分流。将一个超声流量稀释传感器夹在管道上,并连接到一台改良的HD01监护仪(Transonic Systems公司,纽约州伊萨卡)。向管道内注入1毫升0.9%氯化钠进行校准注射。静脉推注由10 - 20毫升0.9%氯化钠组成。同时,通过热稀释法测量CO(COth;MI 166A,惠普公司,马萨诸塞州安多弗)。每个COth或COus值基于三到五次注射的平均值。通过分流的血流量为10至26毫升/分钟。对14名患者进行了比较。在33次测量中,回归方程为COth = -0.08 + 1.02 COus(r = 0.97)。在22例中,COth与COus的差值小于5%,在9例中差值在5 - 10%范围内,在2例中差值在10 - 20%范围内。在ICU环境中存在动脉和静脉管路使得无需进行心脏导管插入术来测定CO。